Company Monitoring Page for Teva-Pharmaceutical

latest headlines for company on cafepharma

Take 2: Teva refiles for approval of long-acting schizophrenia drug months after FDA rejection
Fierce Pharma
Tue, 11/8/22 - 11:06 am
Tags:
Teva Pharmaceutical, schizophrenia, FDA, mdc-IRM
Teva reaches $523M agreement with New York in latest opioid-related settlement
Endpoints
Sun, 11/6/22 - 01:34 pm
Tags:
Teva Pharmaceutical, New York, legal, opioids, opioid crisis
Teva takes $215M hit from currency effects, but CEO says business is stable otherwise
Fierce Pharma
Thu, 11/3/22 - 12:06 pm
Tags:
Teva Pharmaceutical, earnings, opioids
If at first... pharma’s most drawn-out development timelines revealed
EP Vantage
Thu, 11/3/22 - 10:54 am
Tags:
Kyowa Kirin, Takeda, Eiger BioPharmaceuticals, AstraZeneca, Teva Pharmaceutical, Bavarian Nordic, Halozyme, Novartis, MannKind, drug development
Teva reports data from Huntington’s disease-linked chorea trial
Clinical Trials Arena
Wed, 10/19/22 - 10:54 am
Tags:
Teva Pharmaceutical, Austedo, clinical trials, chorea, Huntington's disease
Teva abused patent system and spread misinformation about a Copaxone rival, European officials say
Fierce Pharma
Mon, 10/10/22 - 06:51 pm
Tags:
Teva Pharmaceutical, Europe, Copaxone, legal, pharma marketing
In 'skinny' label fight between Teva and GSK, Supreme Court asks Biden admin for help
Fierce Pharma
Tue, 10/4/22 - 11:01 am
Tags:
GSK, Teva Pharmaceutical, Joe Biden, Supreme Court, skinny labels
Teva settles price-fixing claims with Georgia for a 'modest' $3.3M
Fierce Pharma
Fri, 09/30/22 - 12:33 pm
Tags:
Teva Pharmaceutical, price fixing, Georgia
A perfect storm: Europe's generic industry weighs cuts to output amid energy crisis, pricing pressures and more
Fierce Pharma
Wed, 09/28/22 - 11:38 am
Tags:
generics, Europe, Teva Pharmaceutical, Sandoz
Teva CEO Schultz likely won't renew employment contract next year: reports
Fierce Pharma
Mon, 09/19/22 - 09:57 pm
Tags:
Teva Pharmaceutical, Kåre Schultz, Pharma CEOs
Teva expects to start paying U.S. opioid settlement in 2023
Reuters
Mon, 09/19/22 - 09:41 am
Tags:
Teva Pharmaceutical, opioids, opioid crisis, Kåre Schultz
Teva fires back at GSK again over potential 'skinny' label SCOTUS case
Endpoints
Thu, 09/8/22 - 04:43 pm
Tags:
Teva Pharmaceutical, GSK, skinny labels, Supreme Court, legal
Teva won't reopen troubled California site, where 300-plus are losing their jobs
Fierce Pharma
Tue, 08/23/22 - 10:27 pm
Tags:
Teva Pharmaceutical, California, layoffs, drug manufacturing
GSK claps back at Teva in 'skinny' label case, arguing verdict doesn't threaten companies who act 'properly'
Fierce Pharma
Tue, 08/23/22 - 10:29 am
Tags:
GSK, Teva Pharmaceutical, generics, legal, skinny labels
TEVA Beats on Q2 Earnings, to Settle Opioid Lawsuit for $4.3B
Yahoo/Zacks.com
Wed, 07/27/22 - 06:45 pm
Tags:
Teva Pharmaceutical, earnings
Teva to pay $4.3B to settle opioid epidemic litigation with states
Endpoints
Wed, 07/27/22 - 10:36 am
Tags:
Teva Pharmaceutical, legal, opioids, opioid crisis
Teva warns 'skinny label' ruling could sow 'competition-killing uncertainty' for generics
Fierce Pharma
Thu, 07/14/22 - 11:47 am
Tags:
Teva Pharmaceutical, Supreme Court, skinny labels, GSK, patents
Teva, AbbVie ink $58M opioid settlement to resolve San Francisco claims
Fierce Pharma
Wed, 07/13/22 - 10:39 am
Tags:
Teva Pharmaceutical, opioids, opioid crisis, San Francisco, legal, AbbVie, Allergan
Teva misled court to avoid opioid responsibility, New York AG says
Fierce Pharma
Mon, 07/11/22 - 06:11 pm
Tags:
Teva Pharmaceutical, New York, legal, opioids, opioid crisis
Teva, after Lupin deal, holds another Austedo generic challenger to a 2033 launch
Fierce Pharma
Sun, 06/12/22 - 08:19 pm
Tags:
Teva Pharmaceutical, Austedo, generics, patents, tardive dyskinesia, Aurobindo

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.